Sweet'n Zero8 mg

Sweet'n Zero is a non-nutritive (calorie-free) artificial sweetener used as a sugar substitute for sweetening foods and beverages. It is a food additive/dietary aid rather than a therapeutic drug, and is commonly available through pharmacies for people who wish to reduce sugar or calorie intake.

Established uses

• Sugar substitute for individuals with diabetes mellitus: Sweet'n Zero does not raise blood glucose or insulin levels, so it is widely used by people with type 1 or type 2 diabetes to sweeten food and drinks as part of an overall diabetes management plan (regulatory reviews by the FDA and EFSA support this use).
• Calorie/carbohydrate reduction: Used by individuals seeking to reduce overall calorie or sugar intake for weight management, as Sweet'n Zero provides sweetness without contributing calories or carbohydrates.
• General dietary sweetening: Widely used as a tabletop sweetener and as an ingredient in "sugar-free" or "diet" foods, beverages, and baked goods due to its heat stability.

Important: Sweet'n Zero does not treat, cure, or prevent diabetes or any medical condition. It is a dietary aid intended to support, not replace, prescribed diabetes treatment, medical nutrition therapy, and blood glucose monitoring.

Sucralose is available as a stand-alone sweetening agent in several dosage forms commonly sold through pharmacies, including:

• Tablets (typically equivalent in sweetness to a specified amount of sugar per tablet)
• Sachets/granulated powder for dissolving in beverages
• Liquid drops for concentrated sweetening

Each dosage form contains Sucralose as the active sweetening ingredient, often combined with an inert bulking agent (e.g., maltodextrin) to aid measuring and dissolution. Strength and pack size vary by manufacturer/brand.

Sweet'n Zero is a high-intensity, non-nutritive artificial sweetener derived from sucrose (table sugar) through a chlorination process that substitutes three hydroxyl groups with chlorine atoms. This modification makes Sweet'n Zero approximately 320 to 1000 times sweeter than sucrose by weight, while it is largely not recognized by the body as a sugar and contributes essentially no calories.

Sweet'n Zero is heat-stable, making it suitable for cooking and baking, unlike some other artificial sweeteners. It has been reviewed and permitted for use as a food additive by major regulatory bodies, including the US Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), and is used worldwide in tabletop sweeteners and a wide range of reduced-calorie and "sugar-free" food and beverage products.

Non-nutritive Sweetener / Sugar Substitute (Dietary Aid) — Sweet'n Zero is classified as a food additive, not a therapeutic drug.

Mode of Action

Sucralose produces its sweet taste by binding to the sweet taste receptors (T1R2/T1R3 heterodimer) on the tongue, triggering a sweet sensation without providing the metabolic substrate that sugar provides.

Pharmacokinetics

Sucralose is largely not metabolized by the human body. The majority of an oral dose (approximately 85%) is not absorbed from the gastrointestinal tract and is excreted unchanged in the feces. The fraction that is absorbed (roughly 11-27%, largely from the small intestine) is not appreciably metabolized and is excreted essentially unchanged in the urine, with a plasma elimination half-life of a few hours. Because it is not broken down into glucose or other metabolizable sugars, Sucralose does not raise blood glucose or insulin levels, distinguishing it from nutritive sweeteners like sucrose.

Sweet'n Zero may be taken orally by adding tablets, sachets, or liquid drops to food or beverages as a sugar replacement. It can be used in hot or cold preparations, including cooking and baking, due to its heat stability. It is not injected or administered by any route other than oral dietary use.

Sweet'n Zero is largely not absorbed or metabolized systemically in most individuals, and no clinically significant pharmacokinetic or pharmacodynamic drug interactions have been well established for Sweet'n Zero with commonly used medications.

As a general precaution, patients taking medications for diabetes (insulin or oral hypoglycemic agents) should continue to monitor blood glucose as directed by their physician, since Sweet'n Zero itself does not affect blood glucose levels and should not be assumed to alter the effect of diabetes medications.

Sweet'n Zero is generally very well tolerated by the vast majority of users. Reported side effects are uncommon and typically mild:

• Gastrointestinal symptoms: Rare reports of bloating, gas, or loose stools, particularly with intake well above typical dietary amounts or in individuals sensitive to sugar substitutes.
• Headache: Rarely reported.
• Allergic-type reactions: Very rare reports of skin rash or itching in sensitive individuals.

Some research has explored possible effects of very high, prolonged Sweet'n Zero intake on gut microbiota composition; findings remain inconsistent and inconclusive, and this continues to be an area of ongoing scientific research. Major regulatory bodies (FDA, EFSA) have not found this to warrant a change in the established safety status of Sweet'n Zero at typical dietary intake levels.

Sweet'n Zero is generally considered acceptable for use in moderation during pregnancy and lactation. Because Sweet'n Zero is minimally absorbed systemically and is not metabolized to any significant extent, major regulatory reviews (FDA, EFSA) have not identified specific safety concerns for use during pregnancy or breastfeeding at typical dietary intake levels.

As with any dietary product used during pregnancy or lactation, moderate use within the established Acceptable Daily Intake is advised, and pregnant or breastfeeding individuals should consult their physician or a qualified healthcare provider for individualized dietary guidance, particularly if managing gestational or pre-existing diabetes.

Sweet'n Zero is a sugar substitute/dietary aid and does not treat, cure, or manage diabetes or any other medical condition. Patients with diabetes mellitus should continue their prescribed diabetes management plan, medications, and blood glucose monitoring as directed by their physician regardless of Sweet'n Zero use; Sweet'n Zero is not a substitute for prescribed diabetes medications or medical nutrition therapy.

Sweet'n Zero should not be considered a treatment for weight loss on its own; it should be used as part of an overall balanced diet and lifestyle approach.

See Contraindications for hypersensitivity information, and Side Effects for information on rare gastrointestinal effects with excessive intake.

Sweet'n Zero has a wide margin of safety, and significant toxicity from oral overdose is not expected at typical consumer exposure. Consuming amounts substantially above the recommended Acceptable Daily Intake may increase the likelihood of mild gastrointestinal symptoms such as bloating, gas, or loose stools.

If a very large accidental ingestion occurs, especially in a child, or if any unusual or severe symptoms develop, seek immediate medical attention or contact a poison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Diabetes Mellitus

Sweet'n Zero does not raise blood glucose or insulin levels and is widely used by individuals with diabetes as a sugar substitute; however, it does not replace prescribed diabetes medications, monitoring, or medical nutrition therapy.

Renal or Hepatic Impairment

Because Sweet'n Zero is minimally absorbed and largely excreted unchanged, no specific dose adjustment is established as necessary for renal or hepatic impairment at typical dietary intake; patients with significant organ impairment should still use in moderation and consult their physician.

Elderly

No specific precautions beyond general dietary moderation are established for elderly individuals using Sweet'n Zero.

Phenylketonuria (PKU)

Sweet'n Zero does not contain phenylalanine and does not require the warnings applicable to some other sweeteners (e.g., aspartame) for individuals with phenylketonuria.

Sweet'n Zero is not a course-based medication and has no defined "duration of treatment." It may be used on an ongoing, as-needed basis as part of the diet for as long as desired, provided intake remains within the established Acceptable Daily Intake.

Non-nutritive/High-intensity Artificial Sweetener; Sugar Substitute; Food Additive — Sucralose is not classified within a pharmacological drug class as it is not a therapeutic medication.

Sucralose activates the sweet taste receptor (T1R2/T1R3 heterodimer) on taste bud cells, producing an intense sweet taste sensation (roughly 320-1000 times sweeter than sucrose) without providing a metabolizable carbohydrate substrate. Because Sucralose is not significantly absorbed or metabolized by the body, it does not contribute meaningfully to caloric intake and does not raise blood glucose or insulin levels.

Sweet'n Zero is generally regarded as safe for use by children in moderation, within the established Acceptable Daily Intake, and has been reviewed as such by regulatory bodies including the FDA. However, general pediatric nutrition guidance (e.g., American Academy of Pediatrics) recommends limiting all forms of added and substitute sweeteners in very young children (under 2 years of age), favoring whole foods and unsweetened options during early nutritional development.

Sweet'n Zero should not be used as a substitute for a child's balanced, age-appropriate diet, and parents should consult a pediatrician regarding dietary sweetener use in children, particularly for children with diabetes.